Literature DB >> 3739010

Relationship between doxorubicin-induced ECG changes and myocardial alterations in rats.

F Villani, E Monti, F Piccinini, L Favalli, E Lanza, A Rozza Dionigi, P Poggi.   

Abstract

The aim of the present study was to evaluate the dose- and time-dependence of the effect displayed by doxorubicin (DXR) on the electrocardiogram (ECG) and to establish the relationship between structural alterations of the myocardium and ECG changes in rats administered DXR, at a dose of 1.5 or 3.0 mg/kg, every 3 days for a total of three administrations. The most interesting findings consisted of a dose-dependent, but reversible prolongation of the QRS complex, and in a dose-dependent and progressive irreversible increase in QaT and, in particular, in SaT duration. Furthermore, animals treated with the higher DXR dose showed a slight increase in serum K+ concentration and a significant decrease in serum Ca2+ levels. A good correlation was found between the morphologic score indicating the degree of observed tissue damage and SaT prolongation. These results therefore support the usefulness of measuring this ECG parameter for monitoring the development of DXR-induced cardiotoxicity in rats.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3739010     DOI: 10.1177/030089168607200315

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  7 in total

1.  Effect of Theobroma cacao L. on the Efficacy and Toxicity of Doxorubicin in Mice Bearing Ehrlich Ascites Carcinoma.

Authors:  Priyanka P Patil; Pukar Khanal; Vishal S Patil; Rajitha Charla; Darasaguppe R Harish; Basanagouda M Patil; Subarna Roy
Journal:  Antioxidants (Basel)       Date:  2022-05-31

2.  Effect of amrinone on anthracycline-induced lethal and cardiac toxicity in mice and rats.

Authors:  F Villani; C Manzotti; M Mella; E Monti; G Savi; F Zunino
Journal:  Med Oncol Tumor Pharmacother       Date:  1990

3.  Prevention of doxorubicin-induced cardiomyopathy by reduced glutathione.

Authors:  F Villani; M Galimberti; F Zunino; E Monti; A Rozza; E Lanza; L Favalli; P Poggi
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

4.  Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury.

Authors:  Mark Baguma-Nibasheka; Tiam Feridooni; Feixiong Zhang; Kishore B S Pasumarthi
Journal:  Cells       Date:  2021-11-03       Impact factor: 6.600

5.  Doxorubicin-Induced Cardiac Toxicity Is Mediated by Lowering of Peroxisome Proliferator-Activated Receptor δ Expression in Rats.

Authors:  Zhih-Cherng Chen; Li-Jen Chen; Juei-Tang Cheng
Journal:  PPAR Res       Date:  2013-02-28       Impact factor: 4.964

6.  Cardioprotective effect of Vedic Guard against doxorubicin-induced cardiotoxicity in rats: A biochemical, electrocardiographic, and histopathological study.

Authors:  Basavaraj C Koti; Shweta Nagathan; Agadihiremath Vishwanathswamy; Pramod C Gadad; Agadihiremath Thippeswamy
Journal:  Pharmacogn Mag       Date:  2013-04       Impact factor: 1.085

7.  Doxorubicin induced heart failure: Phenotype and molecular mechanisms.

Authors:  Maria A Mitry; John G Edwards
Journal:  Int J Cardiol Heart Vasc       Date:  2016-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.